DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on August 8, 2006; DOI: 10.1124/dmd.106.010207


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.010207v1
34/11/1927    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Chizuru Watanabe
Yukio Kato
Tomoko Sugiura
Yoshiyuki Kubo
Tomohiko Wakayama
Shoichi Iseki
Akira Tsuji
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watanabe, C.
Right arrow Articles by Tsuji, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, C.
Right arrow Articles by Tsuji, A.


Received for publication March 27, 2006.
Revised August 1, 2006.
Accepted for publication August 2, 2006.

PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell-surface expression

Chizuru Watanabe 1, Yukio Kato 1, Tomoko Sugiura 1, Yoshiyuki Kubo 1, Tomohiko Wakayama 2, Shoichi Iseki 2, Akira Tsuji 1*

1 Graduate School of Natural Science and Technology, Kanazawa University 2 Graduate School of Medical Science (T.W., R.I.), Kanazawa University

* Address correspondence to: E-mail: tsuji{at}kenroku.kanazawa-u.ac.jp

Abstract

A part of organic cation transporter families (OCT3, OCTN1 and OCTN2) have recently been identified to physically interact with PDZ (PSD95, Dlg and ZO1) domain containing proteins, although the physiological relevance of such interaction has not yet been fully examined. Here we have examined stimulatory effect of PDZK2 (also named NaPi-Cap2 and intestinal and kidney-enriched PDZ protein, IKEPP) on those cation transporters. In HEK293 cells, coexpression with PDZK2 increased the uptake of carnitine by OCTN2 with minimal effect on its substrate recognition specificity, but not for transport activity of OCT3 or OCTN1. The stimulatory effect of PDZK2 on OCTN2 was compatible with approximately two times increase in transport capacity and can be accounted for by the increase in cell-surface expression of OCTN2. Coexpression of PDZK2 did not affect carnitine transport activity of OCTN2 with deletion of the last four amino acids that were found to be important for the interaction, suggesting involvement of physical interaction of the two proteins in increase of cell-surface expression of OCTN2. In mouse kidney, colocalization of PDZK2 and OCTN2 was predominantly located in the region which was close to, but not the same as, the surface of apical membranes where OCTN2 alone was observed, suggesting the existence of OCTN2 in subapical compartment that interacts with PDZK2. The present data have thus proposed "intracellular" pool for OCTN2 that may be relevant to the stabilization of cell-surface expression of OCTN2, thereby increasing transport activity for carnitine.


Key words: absorption, organic cation transport, protein analysis, protein-protein interactions, renal transport, transporters





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.